Poor performance of the determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a national household survey in Swaziland

Journal of Clinical Microbiology

Volumn 52, Issue 10, 2014, Pages 3743-3748

  Duong, Yen T ^a   Mavengere, Yvonne ^b   Patel, Hetal ^a   Moore, Carole ^a   Manjengwa, Julius ^b   Sibandze, Dumile ^d   Rasberry, Christopher ^a   Mlambo, Charmaine ^b   Li, Zhi ^c   Emel, Lynda ^c   Bock, Naomi ^a   Moore, Jan ^a   Nkambule, Rejoice ^d   Justman, Jessica ^b   Reed, Jason ^a   Bicego, George ^e   Ellenberger, Dennis L ^a   Nkengasong, John N ^a   Parekh, Bharat S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Department of Medicine   (United States)

^c USA   (United States)

^d Ministry of Health   (Swaziland)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ANTIGEN DETECTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEALTH SURVEY; HIV RAPID TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID AMPLIFICATION; PREDICTIVE VALUE; REVIEW; SENSITIVITY ANALYSIS; SEROCONVERSION; SEROLOGY; SWAZILAND; ADOLESCENT; BLOOD; CROSS-SECTIONAL STUDY; EVALUATION STUDY; FAMILY SIZE; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNOLOGY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FAMILY CHARACTERISTICS; FEMALE; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SWAZILAND; TIME FACTORS; YOUNG ADULT;

EID: 84907167606     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01989-14     Document Type: Review

References (43)

1. Marum E, Taegtmeyer M, Parekh B, Mugo N, Lembariti S, Phiri M, Moore J, Cheng AS. 2012. "What took you so long?" The impact of PEPFAR on the expansion of HIV testing and counseling services in Africa. J. Acquir. Immune Defic. Syndr. 60(Suppl 3):S63-S69. http://dx.doi.org/10.1097/QAI.0b013e31825f313b.
2. Delaney KP, Branson BM, Uniyal A, Phillips S, Candal D, Owen SM, Kerndt PR. 2011. Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clin. Infect. Dis. 52:257-263. http://dx.doi.org/10.1093/cid/ciq068.
3. Daskalakis D. 2011. HIV diagnostic testing: evolving technology and testing strategies. Top. Antivir. Med. 19:18-22.
4. Pilcher CD, Joaki G, Hoffman IF, Martinson FE, Mapanje C, Stewart PW, Powers KA, Galvin S, Chilongozi D, Gama S, Price MA, Fiscus SA, Cohen MS. 2007. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 21:1723-1730. http://dx.doi.org/10.1097/QAD.0b013e3281532c82.
5. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17: 1871-1879. http://dx.doi.org/10.1097/00002030-200309050-00005.
6. Hollingsworth TD, Anderson RM, Fraser C. 2008. HIV-1 transmission, by stage of infection. J. Infect. Dis. 198:687-693. http://dx.doi.org/10.1086/590501.
7. Powers KA, Ghani AC, Miller WC, Hoffman IF, Pettifor AE, Kamanga G, Martinson FE, Cohen MS. 2011. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: A modelling study. Lancet 378:256-268. http://dx.doi.org/10.1016/S0140-6736(11)60842-8.
8. Brenner BG, Roger M, Routy JP, Moisi D, Ntemgwa M, Matte C, Baril JG, Thomas R, Rouleau D, Bruneau J, Leblanc R, Legault M, Tremblay C, Charest H, Wainberg MA. 2007. High rates of forward transmission events after acute/early HIV-1 infection. J. Infect. Dis. 195:951-959. http://dx.doi.org/10.1086/512088.
9. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T, Nalugoda F, Wabwire-Mangen F, Meehan MP, Quinn TC. 2005. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 191:1403-1409. http://dx.doi.org/10.1086/429411.
10. Bell SK, Little SJ, Rosenberg ES. 2010. Clinical management of acute HIV infection: best practice remains unknown. J. Infect. Dis. 202(Suppl 2): S278-S288. http://dx.doi.org/10.1086/655655.
11. Pilcher CD, Christopoulos KA, Golden M. 2010. Public health rationale for rapid nucleic acid or p24 antigen tests for HIV. J. Infect. Dis. 201(Suppl 1):S7-S15. http://dx.doi.org/10.1086/650393.
12. Pilcher CD, McPherson JT, Leone PA, Smurzynski M, Owen-ODowd J, Peace-Brewer AL, Harris J, Hicks CB, Eron JJ, Jr, Fiscus SA. 2002. Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA 288:216-221. http://dx.doi.org/10.1001/jama.288.2.216.
13. Pilcher CD, Fiscus SA, Nguyen TQ, Foust E, Wolf L, Williams D, Ashby R, ODowd JO, McPherson JT, Stalzer B, Hightow L, Miller WC, Eron JJ, Jr, Cohen MS, Leone PA. 2005. Detection of acute infections during HIV testing in North Carolina. N. Engl. J. Med. 352:1873-1883. http://dx.doi.org/10.1056/NEJMoa042291.
14. Stekler J, Swenson PD, Wood RW, Handsfield HH, Golden MR. 2005. Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men. AIDS 19:1323-1325. http://dx.doi.org/10.1097/01.aids.0000180105.73264.81.
15. Truong HM, Grant RM, McFarland W, Kellogg T, Kent C, Louie B, Wong E, Klausner JD. 2006. Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance. AIDS 20: 2193-2197. http://dx.doi.org/10.1097/01.aids.0000252059.85236.af.
16. Patel P, Mackellar D, Simmons P, Uniyal A, Gallagher K, Bennett B, Sullivan TJ, Kowalski A, Parker MM, LaLota M, Kerndt P, Sullivan PS. 2010. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch. Intern. Med. 170:66-74. http://dx.doi.org/10.1001/archinternmed.2009.445.
17. Eshleman SH, Khaki L, Laeyendecker O, Piwowar-Manning E, Johnson-Lewis L, Husnik M, Koblin B, Coates T, Chesney M, Vallari A, Devare SG, Hackett J, Jr. 2009. Detection of individuals with acute HIV-1 infection using the Architect HIV Ag/Ab combo assay. J. Acquir. Immune Defic. Syndr. 52: 121-124. http://dx.doi.org/10.1097/QAI.0b013e3181ab61e1.
18. Branson BM. 2010. The future of HIV testing. J. Acquir. Immune Defic. Syndr. 55(Suppl 2):S102-S105. http://dx.doi.org/10.1097/QAI.0b013e3181fbca44.
19. Alere Diagnostics. 2011. Package insert. Alere Determine HIV 1&2 Ag/Ab combo. Alere Medical Co., Ltd., Chiba, Japan.
20. Beelaert G, Fransen K. 2010. Evaluation of a rapid and simple fourthgeneration HIV screening assay for qualitative detection of HIV p24 antigen and/or antibodies to HIV-1 and HIV-2. J. Virol. Methods 168:218-222. http://dx.doi.org/10.1016/j.jviromet.2010.06.002.
21. Laperche S, Leballais L, Ly TD, Plantier JC. 2012. Failures in the detection of HIV p24 antigen with the Determine HIV-1/2 Ag/Ab combo rapid test. J. Infect. Dis. 206:1946-1947. http://dx.doi.org/10.1093/infdis/jis616.
22. Rosenberg NE, Kamanga G, Phiri S, Nsona D, Pettifor A, Rutstein SE, Kamwendo D, Hoffman IF, Keating M, Brown LB, Ndalama B, Fiscus SA, Congdon S, Cohen MS, Miller WC. 2012. Detection of acute HIV infection: A field evaluation of the determine(R) HIV-1/2 Ag/Ab combo test. J. Infect. Dis. 205:528-534. http://dx.doi.org/10.1093/infdis/jir789.
23. Kilembe W, Keeling M, Karita E, Lakhi S, Chetty P, Price MA, Makkan H, Latka M, Likoti M, Ilukui K, Hurlston M, Allen S, Stevens G, Hunter E. 2012. Failure of a novel, rapid antigen and antibody combination test to detect antigen-positive HIV infection in African adults with early HIV infection. PLoS One 7:e37154. http://dx.doi.org/10.1371/journal.pone.0037154.
24. Brauer M, De Villiers JC, Mayaphi SH. 2013. Evaluation of the Determine fourth generation HIV rapid assay. J. Virol. Methods 189:180-183. http://dx.doi.org/10.1016/j.jviromet.2013.01.017.
25. Fox J, Dunn H, OShea S. 2011. Low rates of p24 antigen detection using a fourth-generation point of care HIV test. Sex. Transm. Infect. 87:178-179. http://dx.doi.org/10.1136/sti.2010.042564.
26. Bhowan K, Kalk E, Khan S, Sherman G. 2011. Identifying HIV infection in South African women: how does a fourth generation HIV rapid test perform? Afr. J. Lab. Med. 1:1-5. http://dx.doi.org/10.4102/ajlm.v1i1.4.
27. Chetty V, Moodley D, Chuturgoon A. 2012. Evaluation of a 4th generation rapid HIV test for earlier and reliable detection of HIV infection in pregnancy. J. Clin. Virol. 54:180-184. http://dx.doi.org/10.1016/j.jcv.2012.02.021.
28. Taegtmeyer M, MacPherson P, Jones K, Hopkins M, Moorcroft J, Lalloo DG, Chawla A. 2011. Programmatic evaluation of a combined antigen and antibody test for rapid HIV diagnosis in a community and sexual health clinic screening programme. PLoS One 6:e28019. http://dx.doi.org/10.1371/journal.pone.0028019.
29. Xia Q, Nonoyama A, Molitor F, Webb D, Osmond D. 2011. Recent decline in the incidence of human immunodeficiency virus infection among California men who have sex with men. Am. J. Epidemiol. 174: 203-210. http://dx.doi.org/10.1093/aje/kwr054.
30. Bicego GT, Nkambule R, Peterson I, Reed J, Donnell D, Ginindza H, Duong YT, Patel H, Bock N, Philip N, Mao C, Justman J. 2013. Recent patterns in population-based HIV prevalence in Swaziland. PLoS One 8:e77101. http://dx.doi.org/10.1371/journal.pone.0077101.
31. Bicego GT, Nkambule R, Peterson I, Reed J, Donnell D, Ginindza H, Duong YT, Patel H, Bock N, Phillip N, Mao C, Justman J. 2013. Recent patterns in population-based HIV prevalence in Swaziland. PLoS One 8:e77101. http://dx.doi.org/10.1371/journal.pone.0077101.
32. Patel P, Bennett B, Sullivan T, Parker MM, Heffelfinger JD, Sullivan PS. 2012. Rapid HIV screening: missed opportunities for HIV diagnosis and prevention. J. Clin. Virol. 54:42-47. http://dx.doi.org/10.1016/j.jcv.2012.01.022.
33. Faraoni S, Rocchetti A, Gotta F, Ruggiero T, Orofino G, Bonora S, Ghisetti V. 2013. Evaluation of a rapid antigen and antibody combination test in acute HIV infection. J. Clin. Virol. 57:84-87. http://dx.doi.org/10.1016/j.jcv.2013.01.007.
34. Jones CB, Kuldanek K, Muir D, Phekoo K, Black A, Sacks R, Smith A, Fidler S. 2012. Clinical evaluation of the Determine HIV-1/2 Ag/Ab combo test. J. Infect. Dis. 206:1947-1949. http://dx.doi.org/10.1093/infdis/jis617.
35. van den Berk GE, Frissen PH, Regez RM, Rietra PJ. 2003. Evaluation of the rapid immunoassay determine HIV 1/2 for detection of antibodies to human immunodeficiency virus types 1 and 2. J. Clin. Microbiol. 41: 3868-3869. http://dx.doi.org/10.1128/JCM.41.8.3868-3869.2003.
36. Piwowar-Manning EM, Tustin NB, Sikateyo P, Kamwendo D, Chipungu C, Maharaj R, Mushanyu J, Richardson BA, Hillier S, Brooks Jackson J. 2010. Validation of rapid HIV antibody tests in 5 African countries. J. Int. Assoc. Physicians AIDS Care (Chic) 9:170-172. http://dx.doi.org/10.1177/1545109710368151.
37. Pavie J, Rachline A, Loze B, Niedbalski L, Delaugerre C, Laforgerie E, Plantier JC, Rozenbaum W, Chevret S, Molina JM, Simon F. 2010. Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: A real-time comparison in a healthcare setting. PLoS One 5:e11581. http://dx.doi.org/10.1371/journal.pone.0011581.
38. Parekh BS, Kalou MB, Alemnji G, Ou CY, Gershy-Damet GM, Nkengasong JN. 2010. Scaling up HIV rapid testing in developing countries: comprehensive approach for implementing quality assurance. Am. J. Clin. Pathol. 134:573-584. http://dx.doi.org/10.1309/AJCPTDIMFR00IKYX.
39. Parekh BS, Hanson DL, Hargrove J, Branson B, Green T, Dobbs T, Constantine N, Overbaugh J, McDougal JS. 2011. Determination of mean recency period for estimation of HIV type 1 incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res. Hum. Retroviruses 27:265-273. http://dx.doi.org/10.1089/aid.2010.0159.
40. Maphalala G, Okello V, Mndzebele S, Gwebu P, Mulima N, Dlamini S, Nhlabatsi B, Ginindza T, Ghebrenegus Y, Ntilivamunda A, Mwanyumba F, Ledwaba J, Pillay V, Bennett DE. 2008. Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006. Antivir. Ther. 13(Suppl 2):S95-S100.
41. Tang S, Hewlett I. 2010. Nanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigen. J. Infect. Dis. 201(Suppl 1):S59-S64. http://dx.doi.org/10.1086/650386.
42. Pascual A, Cachafeiro A, Funk ML, Fiscus SA. 2002. Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor human immunodeficiency virus RNA assay. J. Clin. Microbiol. 40:2472-2475. http://dx.doi.org/10.1128/JCM.40.7.2472-2475.2002.
43. Hargrove J, van Schalkwyk C, Eastwood H. 2012. BED estimates of HIV incidence: resolving the differences, making things simpler. PLoS One 7:e29736. http://dx.doi.org/10.1371/journal.pone.0029736.